FDA authorizes updated Novavax COVID-19 vaccine for better protection against circulating variant. Learn more.
FDA grants marketing authorization for DNA test assessing predisposition for multiple cancer types.
FDA launches pilot program to accelerate rare disease therapies, improving communication between sponsors and FDA staff. #RareDiseaseTherapies #FDA #ClinicalTrials
FDA authorizes updated mRNA COVID-19 vaccines targeting circulating variants for enhanced protection.
U.S. Food and Drug Administration granted marketing authorization for the Cue COVID-19 Molecular Test.
FDA releases draft recommendations to modernize clinical trials, incorporating RWE, technology, and increasing diversity.
FDA clears Beta Bionics iLet ACE Pump & iLet Dosing Decision Software for people with type 1 diabetes.
FDA supports DCTs, increasing accessibility, diversity, and efficiency in medical research.
H2O Therapeutics and AmerisourceBergen collaborate to support the commercialization of FDA-cleared Parky app for Parkinson's Disease.
The U.S. Food and Drug Administration (FDA) has amended the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines to simplify the...
